Effects of amlodipine on coronary hemodynamics and vascular responses to sympathetic stimulation in patients with coronary heart disease

A. Saino, G. Pomidossi, R. Perondi, L. Gregorini, A. Rimini, P. Alessio, A. Zanchetti, G. Mancia

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Dihydropyridines (DHPs) exert a powerful coronary vasodilator action, but whether they actually affect the coronary vasomotor effects elicited by an increase in cardiac sympathetic drive is controversial. We assessed the effects of the DHP calcium antagonist amlodipine on coronary hemodynamics and vascular response to sympathetic activation in patients with coronary heart disease. In the control condition, mean arterial pressure (MAP, aortic catheter), heart rate (HR, ECG), rate-pressure product (RPP), coronary sinus blood flow (CBF, thermodilution) and coronary vascular resistance (CVR) (ratio between MAP and CBF) were measured in all our case series (13 patients with angiographically documented severe coronary artery disease) before and during a 2-min cold pressor test (CPT) and a 30-s diving (D) and, in the 8 patients of this case series who were smokers, also before and during smoking a cigarette (S, nicotine content 1.0 mg for 10 min). The same protocol used in control condition was repeated 30 min after intravenous (i.v.) bolus administration of 11 mg amlodipine. CPT, diving, and smoking increased MAP and RPP and caused a marked and significant increase in CVR (+12.1 ± 4.8, +30.4 ± 6.8, and +16.8 ± 7.2%, respectively). Amlodipine reduced MAP, increased CBF, and caused a marked decrease in CBF. The drug did not modify responses to CPT and diving or pressure and HR responses to smoking, whereas the smoking-induced increase in coronary vascular resistance was attenuated after amlodipine administration (+3.2 ± 2.7%, p <0.05 vs. control condition). Thus, amlodipine does not attenuate the sympathetic coronary vasoconstrictor effects of CPT and diving. However, owing to marked reduction in baseline coronary vasomotor tone, sympathetic stimuli elicit less peak coronary vasoconstriction after administration than before administration of amlodipine. The drug also attenuates coronary vasoconstriction to smoking, presumably because this stimulus is not entirely sympathetic.

Original languageEnglish
Pages (from-to)875-882
Number of pages8
JournalJournal of Cardiovascular Pharmacology
Volume24
Issue number6
Publication statusPublished - 1994

Fingerprint

Amlodipine
Coronary Disease
Blood Vessels
Diving
Hemodynamics
Smoking
Vascular Resistance
Dihydropyridines
Vasoconstriction
Pressure
Thermodilution
Coronary Sinus
Vasoconstrictor Agents
Vasodilator Agents
Nicotine
Pharmaceutical Preparations
Intravenous Administration
Coronary Artery Disease
Arterial Pressure
Electrocardiography

Keywords

  • calcium antagonists
  • cigarette smoking
  • coronary artery disease
  • sympathetic coronary vasoconstriction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Cite this

Saino, A., Pomidossi, G., Perondi, R., Gregorini, L., Rimini, A., Alessio, P., ... Mancia, G. (1994). Effects of amlodipine on coronary hemodynamics and vascular responses to sympathetic stimulation in patients with coronary heart disease. Journal of Cardiovascular Pharmacology, 24(6), 875-882.

Effects of amlodipine on coronary hemodynamics and vascular responses to sympathetic stimulation in patients with coronary heart disease. / Saino, A.; Pomidossi, G.; Perondi, R.; Gregorini, L.; Rimini, A.; Alessio, P.; Zanchetti, A.; Mancia, G.

In: Journal of Cardiovascular Pharmacology, Vol. 24, No. 6, 1994, p. 875-882.

Research output: Contribution to journalArticle

Saino, A, Pomidossi, G, Perondi, R, Gregorini, L, Rimini, A, Alessio, P, Zanchetti, A & Mancia, G 1994, 'Effects of amlodipine on coronary hemodynamics and vascular responses to sympathetic stimulation in patients with coronary heart disease', Journal of Cardiovascular Pharmacology, vol. 24, no. 6, pp. 875-882.
Saino, A. ; Pomidossi, G. ; Perondi, R. ; Gregorini, L. ; Rimini, A. ; Alessio, P. ; Zanchetti, A. ; Mancia, G. / Effects of amlodipine on coronary hemodynamics and vascular responses to sympathetic stimulation in patients with coronary heart disease. In: Journal of Cardiovascular Pharmacology. 1994 ; Vol. 24, No. 6. pp. 875-882.
@article{44db2afad8db4a0197c5b717de8d849f,
title = "Effects of amlodipine on coronary hemodynamics and vascular responses to sympathetic stimulation in patients with coronary heart disease",
abstract = "Dihydropyridines (DHPs) exert a powerful coronary vasodilator action, but whether they actually affect the coronary vasomotor effects elicited by an increase in cardiac sympathetic drive is controversial. We assessed the effects of the DHP calcium antagonist amlodipine on coronary hemodynamics and vascular response to sympathetic activation in patients with coronary heart disease. In the control condition, mean arterial pressure (MAP, aortic catheter), heart rate (HR, ECG), rate-pressure product (RPP), coronary sinus blood flow (CBF, thermodilution) and coronary vascular resistance (CVR) (ratio between MAP and CBF) were measured in all our case series (13 patients with angiographically documented severe coronary artery disease) before and during a 2-min cold pressor test (CPT) and a 30-s diving (D) and, in the 8 patients of this case series who were smokers, also before and during smoking a cigarette (S, nicotine content 1.0 mg for 10 min). The same protocol used in control condition was repeated 30 min after intravenous (i.v.) bolus administration of 11 mg amlodipine. CPT, diving, and smoking increased MAP and RPP and caused a marked and significant increase in CVR (+12.1 ± 4.8, +30.4 ± 6.8, and +16.8 ± 7.2{\%}, respectively). Amlodipine reduced MAP, increased CBF, and caused a marked decrease in CBF. The drug did not modify responses to CPT and diving or pressure and HR responses to smoking, whereas the smoking-induced increase in coronary vascular resistance was attenuated after amlodipine administration (+3.2 ± 2.7{\%}, p <0.05 vs. control condition). Thus, amlodipine does not attenuate the sympathetic coronary vasoconstrictor effects of CPT and diving. However, owing to marked reduction in baseline coronary vasomotor tone, sympathetic stimuli elicit less peak coronary vasoconstriction after administration than before administration of amlodipine. The drug also attenuates coronary vasoconstriction to smoking, presumably because this stimulus is not entirely sympathetic.",
keywords = "calcium antagonists, cigarette smoking, coronary artery disease, sympathetic coronary vasoconstriction",
author = "A. Saino and G. Pomidossi and R. Perondi and L. Gregorini and A. Rimini and P. Alessio and A. Zanchetti and G. Mancia",
year = "1994",
language = "English",
volume = "24",
pages = "875--882",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Effects of amlodipine on coronary hemodynamics and vascular responses to sympathetic stimulation in patients with coronary heart disease

AU - Saino, A.

AU - Pomidossi, G.

AU - Perondi, R.

AU - Gregorini, L.

AU - Rimini, A.

AU - Alessio, P.

AU - Zanchetti, A.

AU - Mancia, G.

PY - 1994

Y1 - 1994

N2 - Dihydropyridines (DHPs) exert a powerful coronary vasodilator action, but whether they actually affect the coronary vasomotor effects elicited by an increase in cardiac sympathetic drive is controversial. We assessed the effects of the DHP calcium antagonist amlodipine on coronary hemodynamics and vascular response to sympathetic activation in patients with coronary heart disease. In the control condition, mean arterial pressure (MAP, aortic catheter), heart rate (HR, ECG), rate-pressure product (RPP), coronary sinus blood flow (CBF, thermodilution) and coronary vascular resistance (CVR) (ratio between MAP and CBF) were measured in all our case series (13 patients with angiographically documented severe coronary artery disease) before and during a 2-min cold pressor test (CPT) and a 30-s diving (D) and, in the 8 patients of this case series who were smokers, also before and during smoking a cigarette (S, nicotine content 1.0 mg for 10 min). The same protocol used in control condition was repeated 30 min after intravenous (i.v.) bolus administration of 11 mg amlodipine. CPT, diving, and smoking increased MAP and RPP and caused a marked and significant increase in CVR (+12.1 ± 4.8, +30.4 ± 6.8, and +16.8 ± 7.2%, respectively). Amlodipine reduced MAP, increased CBF, and caused a marked decrease in CBF. The drug did not modify responses to CPT and diving or pressure and HR responses to smoking, whereas the smoking-induced increase in coronary vascular resistance was attenuated after amlodipine administration (+3.2 ± 2.7%, p <0.05 vs. control condition). Thus, amlodipine does not attenuate the sympathetic coronary vasoconstrictor effects of CPT and diving. However, owing to marked reduction in baseline coronary vasomotor tone, sympathetic stimuli elicit less peak coronary vasoconstriction after administration than before administration of amlodipine. The drug also attenuates coronary vasoconstriction to smoking, presumably because this stimulus is not entirely sympathetic.

AB - Dihydropyridines (DHPs) exert a powerful coronary vasodilator action, but whether they actually affect the coronary vasomotor effects elicited by an increase in cardiac sympathetic drive is controversial. We assessed the effects of the DHP calcium antagonist amlodipine on coronary hemodynamics and vascular response to sympathetic activation in patients with coronary heart disease. In the control condition, mean arterial pressure (MAP, aortic catheter), heart rate (HR, ECG), rate-pressure product (RPP), coronary sinus blood flow (CBF, thermodilution) and coronary vascular resistance (CVR) (ratio between MAP and CBF) were measured in all our case series (13 patients with angiographically documented severe coronary artery disease) before and during a 2-min cold pressor test (CPT) and a 30-s diving (D) and, in the 8 patients of this case series who were smokers, also before and during smoking a cigarette (S, nicotine content 1.0 mg for 10 min). The same protocol used in control condition was repeated 30 min after intravenous (i.v.) bolus administration of 11 mg amlodipine. CPT, diving, and smoking increased MAP and RPP and caused a marked and significant increase in CVR (+12.1 ± 4.8, +30.4 ± 6.8, and +16.8 ± 7.2%, respectively). Amlodipine reduced MAP, increased CBF, and caused a marked decrease in CBF. The drug did not modify responses to CPT and diving or pressure and HR responses to smoking, whereas the smoking-induced increase in coronary vascular resistance was attenuated after amlodipine administration (+3.2 ± 2.7%, p <0.05 vs. control condition). Thus, amlodipine does not attenuate the sympathetic coronary vasoconstrictor effects of CPT and diving. However, owing to marked reduction in baseline coronary vasomotor tone, sympathetic stimuli elicit less peak coronary vasoconstriction after administration than before administration of amlodipine. The drug also attenuates coronary vasoconstriction to smoking, presumably because this stimulus is not entirely sympathetic.

KW - calcium antagonists

KW - cigarette smoking

KW - coronary artery disease

KW - sympathetic coronary vasoconstriction

UR - http://www.scopus.com/inward/record.url?scp=0028648820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028648820&partnerID=8YFLogxK

M3 - Article

C2 - 7898068

AN - SCOPUS:0028648820

VL - 24

SP - 875

EP - 882

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 6

ER -